Virgil Thompson

Virgil Thompson

No open positions remaining
86 year
Health Technology
Consumer Services
Commercial Services

Profile

Virgil D.
Thompson
served as President, CEO, and Director at various pharmaceutical companies including Splash Pharmaceuticals, Cytel Corp., Chimeric Therapies, Cibus Pharmaceuticals, Questcor Pharmaceuticals, and Savient Pharmaceuticals.
He also served as Chairman at Questcor Pharmaceuticals and Spinnaker Biosciences, and as an Independent Director at Soligenix, Aradigm Corp., GenZ Corp., and Processa Pharmaceuticals.
Thompson was also a Director at Mallinckrodt Plc and Promet Therapeutics LLC.
Prior to his work in the pharmaceutical industry, Thompson served as President of Syntex Laboratories, Inc. and as COO of Syntex Corp.
Thompson received his undergraduate degree from the University of Kansas and his graduate degree from George Washington University Law School.

Former positions of Virgil Thompson

CompaniesPositionEnd
Chief Executive Officer 01/07/2015
PROCESSA PHARMACEUTICALS, INC. Director/Board Member 09/11/2023
ARADIGM CORPORATION Chairman 01/07/2017
Director/Board Member 01/01/2017
QUESTCOR PHARMACEUTICALS INC Chairman 14/08/2014
See the detail of Virgil Thompson's experience

Training of Virgil Thompson

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

64

1st degree connections

17

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies17

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Consumer Services

Syntex Laboratories, Inc.

Cytel Corp.

Chimeric Therapies, Inc.

Cibus Pharmaceuticals, Inc.

Health Services

Consumer Services

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. Virgil Thompson
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!